Samantha McLemore Patient Capital Management
Samantha McLemore is the founder of Patient Capital Management and previously worked closely with Bill Miller on value-oriented strategies. Her firm emphasizes long-term, research-driven equity investing with a willingness to hold unconventional or out-of-favor ideas. McLemore’s portfolio is followed by investors who track the next generation of independent value managers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$4.65M |
| 2 |
Peloton Interactive
PTON
|
+$2.77M |
| 3 |
EXE
Expand Energy Corp
EXE
|
+$2.18M |
| 4 |
Capital One
COF
|
+$1.26M |
| 5 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$1.09M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DXC Technology
DXC
|
+$2.74M |
| 2 |
SI
Silvergate Capital Corporation
SI
|
+$2.36M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$2.04M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$1.37M |
| 5 |
Ovintiv
OVV
|
+$975K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 35.12% |
| 2 | Financials | 20.01% |
| 3 | Energy | 10.57% |
| 4 | Industrials | 9.11% |
| 5 | Technology | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
UBS Group
UBS
$163B
| $4.75M | 2.12% |
+222,800
| New | +$4.65M |
|
27
Cleveland-Cliffs
CLF
$6.43B
| $4.74M | 2.11% |
258,325
-21,275
| -8% | -$421K |
|
28
Rocket Companies
RKT
$39.4B
| $4.6M | 2.05% |
507,700
| – | – |
|
|
KRTX
29
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $4.25M | 1.89% |
23,375
+5,675
| +32% | +$1.09M |
|
|
30
Capital One
COF
$134B
| $3.91M | 1.74% |
40,700
+12,000
| +42% | +$1.26M |
|
|
31
Peloton Interactive
PTON
$2.37B
| $3.75M | 1.67% |
330,725
+230,725
| +231% | +$2.77M |
|
|
SFIX
32
Stitch Fix
SFIX
$446M
| $3.26M | 1.45% |
638,100
-24,250
| -4% | -$114K |
|
33
SoFi Technologies
SOFI
$24.4B
| $2.85M | 1.27% |
469,700
| – | – |
|
|
QUOT
34
DELISTED
Quotient Technology Inc
QUOT
| $2.69M | 1.2% |
819,400
| – | – |
|
35
ADT
ADT
$5.39B
| $2.33M | 1.04% |
322,300
-57,500
| -15% | -$469K |
|
36
Precigen
PGEN
$2.58B
| $1.55M | 0.69% |
1,463,760
+665,560
| +83% | +$960K |
|
|
37
DXC Technology
DXC
$1.73B
| $1.53M | 0.68% |
60,000
-100,600
| -63% | -$2.74M |
|
38
Diamondback Energy
FANG
$59B
| $1.35M | 0.6% |
10,000
-2,800
| -22% | -$390K |
|
39
Lennar Class B
LEN.B
$20.6B
| $1.12M | 0.5% |
13,150
| – | – |
|
40
Vontier
VNT
$4.46B
| $1.09M | 0.49% |
40,000
| – | – |
|
41
Bank of America
BAC
$431B
| $715K | 0.32% |
25,000
| – | – |
|
42
CALL
Coinbase
COIN
$49.2B
| – | – |
-51,500
| Closed | -$1.82M |
|
|
SI
43
DELISTED
Silvergate Capital Corporation
SI
| – | – |
-135,600
| Closed | -$2.36M |
|
Similar funds
Samantha McLemore's Q1 2023 Portfolio in Review
As of Q1 2023, Samantha McLemore held 44 positions worth $224M, up 9% from $206M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Samantha McLemore's Q1 2023 filing shows 1 new, 11 increased, 18 reduced and 3 closed positions. Its largest new stake was UBS Group: 222,800 shares worth $4.75M. The largest sale was DXC Technology, an estimated $2.74M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, up from 32% a quarter earlier, followed by Financials and Energy.
- Samantha McLemore's largest Q1 2023 buy was UBS Group: 222,800 shares worth $4.75M.
- Samantha McLemore added most to Peloton Interactive in Q1 2023, an estimated $2.77M increase.
- Samantha McLemore's biggest Q1 2023 reduction was DXC Technology, cutting an estimated $2.74M.
- Samantha McLemore fully exited Silvergate Capital Corporation in Q1 2023, selling an estimated $2.36M.
- Samantha McLemore's ten largest holdings make up 40% of its $224M portfolio in Q1 2023.
- Samantha McLemore opened 1 new position and closed 3 in Q1 2023.
- Samantha McLemore's portfolio value rose 9% quarter-over-quarter to $224M.
Based on Patient Capital Management's 13F filing for Q1 2023, filed 15 May 2023.